Found 0 matching trials
Autologous Transplantation for Chronic Myelogenous Leukemia PHASE2 The goal of this clinical research is to learn if treatment with high-dose ...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine PHASE2 This is a genetic disease (transmitted through the parents' genes) called F...
Show More Location
Children's Hospital Boston
Learn More & Join Trial
Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT PHASE2 The purpose of this study is to evaluate the safety and efficacy of Melphal...
Show More Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Learn More & Join Trial
Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation PHASE2 The purpose of this study is to extend the use of Tacrolimus and Sirolimus ...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Sickle Cell Disease Conditioning for Bone Marrow Transplant PHASE1 Most bone marrow transplants for children with sickle cell disease are perf...
Show More Location
University of Alabama-Birmingham
Learn More & Join Trial
Unrelated Double Umbilical Cord Blood Units Transplantation PHASE2 The purpose of this study is to determine the safety and feasibility of unr...
Show More Location
Hematology-Oncology & SCT Research Center
Learn More & Join Trial
Busulfan and Fludarabine in Patients With AML and MDS PHASE2 Primary Objectives:
1. To administer multiple doses of an intravenous form...
Show More Location
U.T.M.D. Anderson Cancer Center
Learn More & Join Trial
Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia PHASE3 RATIONALE: Interferon alfa may interfere with the growth of cancer cells. D...
Show More Location
Hackensack University Medical Center
Learn More & Join Trial
A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT PHASE1 This is a phase trial to determine the maximum tolerated dose (MTD) of clof...
Show More Location
Indiana University Cancer Center
Learn More & Join Trial
Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant PHASE1 This protocol is designed for a single specific patient. It uses busulfan a...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial